Eurofarma Innovation and Growth Strategy
2
DISCLAIMER
This presentation may contain information
about future events, such information would not
only be historical facts, but would reflect the wishes
and expectations of the company's management.
The words "believes", "expects", "plans",
"forecasts", "estimates", "projects", "aims" and the
like are intended to identify statements that
necessarily involve known and unknown risks.
Known risks include uncertainties, which are
not limited to the impact of price and service
competitiveness, acceptance of services in the
market, service transactions by the company and
its competitors, regulatory approval, currency
fluctuation, changes in the mix of services offered
and other risks described in the Company's reports.
This presentation includes accounting and non-
accounting data. Non-accounting data has not
been subject to review by the Company's
independent auditors.
Certain percentages and other amounts
included in this document have been rounded
up to facilitate their presentation. The scales of
the charts can appear in different proportions, to
optimize the demonstration. Accordingly, the
numbers and charts presented may not represent
the arithmetic sum and the appropriate scale of the
numbers that precede them and may differ from
those presented in the financial statements.
This presentation does not constitute or should
be considered an offer or solicitation to buy or
sell any financial instrument or to participate in any
specific business strategy.
This presentation was updated as of June 30,
2022, and the Company does not assume any
obligation to update it in light of new information or
future developments.
eurofarmaView entire presentation